NEW YORK (GenomeWeb News) – Queens University in Belfast said today it will lead a €6 million ($8.3 million) international project that seeks to investigate genes that make bowel cancer so deadly and hard to treat.

Funded by the European Commission's Seventh Framework Programme, the MErCuRIC project will focus on genes that may be involved in a particularly aggressive type of colorectal cancer that affects around 50 percent of CRC patients, and which has a five-year survival rate of less than five percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.